IVF didn’t succeed? Don’t rush into the next cycle—first understand these 4 key stages

"I prepared so much this time—why did it still not work out?"

For families who have been through an IVF cycle, the most natural reaction when results fall short of expectations is anxiety: Is my body just not suited for this? Were the embryos not good enough? Will the next cycle run into the same problems?

But looking at the full assisted reproduction process, a "failed IVF cycle" is rarely a single, simple outcome. From ovarian stimulation and egg retrieval to fertilization and embryo culture, then to transfer, implantation, and early pregnancy—each stage has its own set of contributing factors. Rather than simply labeling one result as "failure," the more important question is: Where exactly did the cycle stop progressing this time?

For families learning about IVF and third-generation IVF in Thailand, or planning fertility treatment abroad or cross-border family building, understanding the four common scenarios below can help make the next conversation with your doctor more productive.

01 Follicles Present, but Fewer Mature Eggs Than Expected

In the first half of an IVF cycle, ovarian stimulation is typically used to help multiple follicles grow in sync, with egg retrieval scheduled at the appropriate time.

In reality, entering a stimulation cycle does not guarantee the expected number of mature eggs. Some women have relatively lower ovarian reserve; others may not respond ideally to stimulation medication; and some may show promising follicle counts during monitoring but still end up with fewer mature eggs than anticipated. When this happens, one of the first indicators to look at is AMH (Anti-Müllerian Hormone).

What does AMH actually tell us?

AMH is commonly used as a supplementary indicator of a woman's ovarian reserve. It is important to note, however: AMH primarily reflects the quantity aspect of ovarian reserve. It does not, on its own, represent egg quality, nor can a single AMH value determine the final outcome. Doctors typically combine it with age, antral follicle count (AFC), baseline hormone levels, previous stimulation response, and prior egg retrieval results for a full assessment.

What if AMH is low?

Low AMH usually means the number of recruitable follicles may be relatively limited, but it does not mean there are "no eggs at all."

For women with diminished ovarian reserve, simply increasing medication dosage does not necessarily lead to more mature eggs. Some doctors may therefore consider adjusting stimulation intensity, protocol design, or the timing of retrieval based on individual circumstances. What truly matters here is not chasing the goal of "retrieving as many eggs as possible in one cycle," but rather: how to design a protocol suited to the individual's specific ovarian reserve situation.

For those with lower ovarian reserve, advanced age, or a history of poor stimulation response, doctors may also discuss options such as mild stimulation, minimal stimulation, or multi-cycle embryo accumulation. The right approach depends on the individual's situation—there is no one-size-fits-all "universal stimulation protocol."

What if AMH is not low, but egg retrieval still falls short?

In this case, ovarian reserve alone is not the only factor to examine. It is worth reviewing further: Was the stimulation protocol a good match? Did medication dosages need adjustment? Were follicles developing in sync? Was trigger timing appropriate? What was the proportion of mature eggs at retrieval? What patterns were observed in the response to medication in previous cycles?

IVF is never a standardized assembly line. Two people of the same age with similar AMH levels may require completely different stimulation approaches. So after one less-than-ideal retrieval, the more constructive step is to have your doctor thoroughly review the full cycle data, rather than simply repeating the same protocol.

02 Eggs Retrieved, but Not the Embryos Expected

The second common scenario is when the egg retrieval count looks reasonable, but the number of embryos steadily drops through fertilization, cleavage, and blastocyst culture.

Many first-time IVF patients wonder: "I had over a dozen eggs retrieved—why did only a few embryos make it?" In fact, the journey from eggs to transferable or testable embryos is, by nature, a stepwise selection process. It broadly follows:

Eggs Retrieved → Mature Eggs → Normal Fertilization → Cleavage-Stage Embryos → Blastocysts

At every step, some embryos may stop developing. Therefore, "number of eggs retrieved" cannot be equated with "number of embryos ultimately available."

Why do embryos decrease during culture?

There are many contributing factors, and the first to consider are the sperm and the egg themselves. As a woman's age increases, both the quantity and quality of oocytes may change, and the likelihood of chromosomal abnormalities in embryos also tends to rise with age.

Male factors should not be overlooked either. Semen analysis parameters, sperm motility, morphology, and in some cases sperm DNA integrity (which some doctors assess) can all be part of the evaluation.

So if multiple consecutive cycles show consistently low fertilization rates, slow embryo development, or poor blastocyst formation, it is usually worth investigating causes in both partners, rather than placing the blame solely on the female side.

An easily overlooked variable: the embryology laboratory

Once embryos leave the human body, fertilization and early culture take place in a laboratory environment. The lab's culture system, temperature and humidity stability, gas environment, equipment, quality management, and the embryologists' technical experience can all influence the culture process.

This is why, when accompanying clients to visit fertility centers in Thailand, we specifically encourage them to learn about the laboratory. For families considering third-generation IVF in Thailand, it is worth looking beyond decor, pricing, or a single marketing "success rate" figure. Laboratory configuration, embryo culture systems, and the coordination between doctors and the embryology lab deserve equal attention.

03 Embryos Available, but Repeated Implantation Failure

The third scenario is often the most puzzling: "I have what looks like a good embryo—why didn't the transfer lead to the outcome I hoped for?" At this stage, the issue can be viewed through two lenses: the "seed" and the "soil."

The "seed" refers to the embryo itself; the "soil" refers to the uterus and endometrial environment.

First step: re-evaluate the embryo

A good embryo morphology score does not guarantee that its chromosomes are normal. As a woman's age increases, the probability of chromosomal abnormalities in embryos generally rises. This is one of the key reasons PGT (preimplantation genetic testing) in third-generation IVF has drawn so much attention. PGT does not "make ordinary embryos better"—when clinically indicated, it is a testing tool that helps doctors better understand the genetic status of embryos.

So for families planning third-generation IVF in Thailand, when consulting about PGT, it is important to first clarify: why it is being considered, whether it is appropriate for your situation, what is being tested, and what the results actually mean. It should not be understood as "PGT guarantees success."

Second step: evaluate the uterine environment

If the embryo side has already been reasonably well assessed, doctors will typically also consider uterine and endometrial factors in the context of the patient's medical history.

Some people may have conditions such as endometrial polyps, intrauterine adhesions, submucosal fibroids, adenomyosis, chronic endometritis, or hydrosalpinx (tubal fluid). The appropriate tests and management for each condition differ.

Whether hysteroscopy, ultrasound, or other supplementary tests are needed should be determined based on individual history and the doctor's clinical judgment—not every failed transfer requires running every possible test.

Is thicker endometrium always better?

Many people focus heavily on one number when preparing for transfer: endometrial thickness. But clinical assessment is not a case of "if you hit this number, implantation will happen." Doctors typically evaluate thickness alongside endometrial pattern, hormone levels, medical history, embryo status, and transfer timing. So try not to over-anxietize over a single thickness reading, and do not self-medicate or try treatments that have not been properly evaluated.

For those with repeated implantation failure, what is genuinely needed is a systematic review—not stacking on more procedures indiscriminately.

04 Implantation Achieved, but Biochemical Pregnancy or Early Miscarriage Follows

The fourth scenario is often the hardest emotionally. The pregnancy test shows a change, you allow yourself to exhale—and then a biochemical pregnancy or early miscarriage occurs.

Why does pregnancy stop progressing even after implantation has occurred? There is rarely a single cause. Chromosomal abnormalities in the embryo are an important factor in early pregnancy, and the risk generally increases with maternal age. In addition, doctors may evaluate uterine structure, endocrine factors, certain immune or coagulation-related issues, and other relevant medical history depending on the individual.

A single occurrence does not necessarily indicate a serious underlying problem. However, if biochemical pregnancies or miscarriages recur, it is worth bringing your previous test results and cycle records to a reproductive specialist for a more systematic evaluation.

What can PGT actually address?

This is one of the questions families planning third-generation IVF in Thailand ask most often. PGT is performed before embryo transfer, using specific genetic testing on embryos when clinically indicated.

Different types of PGT address different concerns—some focus on chromosomal aneuploidy, others on specific single-gene disorders or chromosomal structural rearrangements. Its core purpose is "screening or testing," not "treating the embryo." So even after PGT, a subsequent pregnancy should not be assumed to be completely risk-free.

When an IVF Cycle Does Not Succeed, These Are the 4 Things Worth Reviewing

Putting the above together, if an IVF cycle does not produce the hoped-for outcome, the clues can generally be traced along the following four directions:

① Egg retrieval fell short of expectations

Focus on ovarian reserve, age, previous stimulation response, protocol design, follicle development, and the proportion of mature eggs.

② Embryo culture results were disappointing

Beyond egg factors, also examine male factors, fertilization rates, embryo development patterns, and laboratory culture conditions.

③ Embryos repeatedly failed to implant

Re-evaluate both the "seed" (embryo) and the "soil" (uterus and endometrium).

④ Biochemical pregnancy or early miscarriage

This needs to be assessed based on the number of occurrences, maternal age, embryo status, genetic factors, and other relevant history—not simplified down to a single test value.

A Message from Global New Life: One Cycle Does Not Define the Final Answer

Over the years, as Global New Life has accompanied families exploring fertility treatment abroad, cross-border family building, and IVF in Thailand, we have often met families who come to us after one or even several disappointing cycles, hoping to find a new direction.

What we have come to understand more deeply over time is this: what many people truly need is not another "the next time will succeed," but someone who can help them carefully reconstruct and clarify every step they have already taken.

What protocol was used before? How many eggs were retrieved? How many were mature? How many fertilized normally? How many day-3 embryos were there? How many blastocysts ultimately formed? Was PGT performed? What stage and quality of embryo was transferred? What uterine and endometrial assessments had been done? When these pieces of information are connected, they often offer far more insight than looking at any single indicator in isolation.

So whether you are learning about IVF in your home country or planning to travel to Thailand for third-generation IVF, we recommend keeping a complete record of your previous test reports, medication logs, embryo culture reports, and transfer records. For families who need overseas medical accompaniment, Global New Life also helps in the early stages with organizing past records, coordinating appointments, translation support, and travel logistics—so that the doctor can gain a fuller understanding of your history.

This article is provided for general educational purposes on assisted reproduction and is intended as a reference for health education and medical consultations. All decisions regarding testing, medication, stimulation protocols, embryo testing, and transfer plans should be made by qualified medical professionals based on individual assessment. This content does not constitute personal diagnosis or treatment advice.